Oseltamivir-resistant influenza a viruses circulating in Japan

J Clin Microbiol. 2009 May;47(5):1424-7. doi: 10.1128/JCM.02396-08. Epub 2009 Mar 4.

Abstract

Surveillance studies of the influenza viruses circulating in Europe and other countries in 2007 and 2008 have revealed rates of resistance to oseltamivir of up to 67% among H1N1 viruses. In the present study, we examined 202 clinical samples obtained from patients infected with H1N1 virus in Japan in 2007 and 2008 for oseltamivir resistance and found that three were oseltamivir resistant (1.5%). The 50% inhibitory concentrations (IC(50)s), as measured by a sialidase inhibition assay with these drug-resistant viruses, were >100-fold higher than those of the nonresistant viruses (median IC(50), 12.6 nmol/liter). The His274Tyr (strain N2 numbering) mutation of the neuraminidase protein, which is known to confer oseltamivir resistance, was detected in these three isolates. Phylogenetic analysis showed that one virus belonged to a lineage that is composed of drug-resistant viruses isolated in Europe and North America and that the other two viruses independently emerged in Japan. Continued surveillance studies are necessary to observe whether these viruses will persist.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution / genetics
  • Antiviral Agents / pharmacology*
  • Cluster Analysis
  • Drug Resistance, Viral*
  • Humans
  • Influenza A Virus, H1N1 Subtype / classification
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Influenza A Virus, H1N1 Subtype / genetics
  • Influenza A Virus, H1N1 Subtype / isolation & purification
  • Influenza, Human / virology*
  • Inhibitory Concentration 50
  • Japan
  • Mutation, Missense
  • Neuraminidase / genetics
  • Oseltamivir / pharmacology*
  • Phylogeny
  • Sequence Homology
  • Viral Proteins / genetics

Substances

  • Antiviral Agents
  • Viral Proteins
  • Oseltamivir
  • Neuraminidase